Clinical Trial: HMPL-453 in Advanced Malignant Mesothelioma

U.S., March 27 -- ClinicalTrials.gov registry received information related to the study (NCT04290325) titled 'HMPL-453 in Advanced Malignant Mesothelioma' on Jan. 17.

Brief Summary: This is a phase II, single arm, multicenter and open-label study to evaluate the efficacy, safety and pharmacokinetic of HMPL-453 in patient with advanced Malignant Mesothelioma

Study Type: Interventional

Condition: Advanced Malignant Mesothelioma

Intervention: Drug: HMPL-453

HMPL-453 tablet

Recruitment Status: Not Yet Recruiting

Sponsor: Hutchison Medipharma Limited

Information provided by (Responsible Party): Hutchison Medipharma Limited

Published by HT Digital Content Services with permission from Health Daily Digest....